no scripts enabled
Medikabazaar
Cart
Renocrit 4000lu Injection
Renocrit 4000lu Injection: Image 1
Renocrit 4000lu Injection: Image 2
Renocrit 4000lu Injection: Image 3

Your Advantages

Brand Zydus

Renocrit 4000IU Injection contains Recombinant Human Erythropoietin Alfa (Epoetin Alfa) 4000 IU, an erythropoiesis-stimulating agent used to treat anemia caused by various medical conditions.

 

Benefits

Renocrit 4000IU Injection stimulates the bone marrow to produce more red blood cells, helping to elevate and sustain red blood cell levels. This action helps reduce symptoms of anemia such as tiredness and weakness.

 

Uses and Indications

  • Anemia associated with chronic kidney disease (CKD).
  • Anemia resulting from cancer chemotherapy.
  • Anemia in HIV-infected individuals undergoing treatment with zidovudine.
  • To lower the need for red blood cell transfusions in patients at high risk for blood loss due to planned surgery or other procedures.

The Renocrit 4000IU Injection contains:

  • Recombinant Human Erythropoietin Alfa (Epoetin Alfa) 4000 IU/0.4 ml (active ingredient).
Active Ingredient(s)Recombinant Human Erythropoietin Alfa (Epoetin Alfa) 4000 IU
Therapeutic ClassErythropoiesis-stimulating agent (ESA)
Storage ConditionsStore in a refrigerator (2 - 8°C); Do not freeze
Regulatory ApprovalRegulated by CDSCO, meets Indian Pharmacopoeia standards
Licensed IndicationsAnemia due to chronic kidney disease; Anemia due to cancer chemotherapy; Anemia due to HIV infection treatment with zidovudine; Reduction of red blood cell transfusions in high-risk surgical patients
Route of AdministrationSubcutaneous (SC) or Intravenous (IV) injection
SchedulePrescription Required

Dosage and Administration

Renocrit 4000IU Injection is administered by injection, either subcutaneously (under the skin) or intravenously (into a vein). The dose depends on body weight and the cause of anemia, and it must be decided by a doctor. Injections are usually given by a nurse or doctor. Iron supplements before and during treatment may enhance effectiveness.

 

Storage and Disposal

  • Store in a refrigerator between 2°C to 8°C.
  • Do not freeze.
  • Keep away from moisture, heat, and light.
  • Keep out of reach of children.

Precautions and Safety

  • Inform your doctor if you have uncontrolled high blood pressure, heart disease, or gout.
  • Tell your doctor about all other medicines you are taking, including prescription, over-the-counter, nutritional, vitamin supplements, and herbal products, as certain medications may interact.
  • Blood pressure should be checked often during treatment.
  • Regular medical tests may be needed to monitor hemoglobin, blood cells, electrolytes (like potassium), and to ensure the medicine is not causing harmful effects.
  • Inform your doctor immediately if you experience symptoms of very high blood pressure (severe headache, vision problems, nausea, vomiting, fits/seizures), shortness of breath, or skin rash.
  • It is not known whether this medicine will harm an unborn baby; tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding.
  • This medicine may increase the risk of blood clots, heart attack, stroke, or congestive heart failure.
  • In cancer patients, epoetin alfa injection may lead to earlier death, tumor growth, or cancer recurrence/spread in some cases. It should only be used for chemotherapy-induced anemia if chemotherapy is expected to continue for at least 2 months and there is not a high chance of cancer cure.

 

Side Effects and Risks

  • Common side effects include nausea, vomiting, fever, increased blood pressure, headache, tiredness, dizziness, aches and pains (flu-like symptoms), rash, joint pain, insomnia, chills, cough, bone pain, muscle spasm, vascular occlusion, injection site irritation, stomatitis, weight loss, decreased white blood cell count (lymphocytes), and increased blood glucose levels.
  • Serious side effects can include seizures (fits) and serious blood clots requiring urgent medical attention.
  • Epoetin alfa may cause pure red cell aplasia (PRCA), a condition leading to severe anemia, if the body makes antibodies to it.

 

Disclaimer

Use this medicine only under the prescription and guidance of a qualified doctor or pharmacist.

twitterlinkedinfacebookinstagramyoutube
@Copyright Boston Ivy Healthcare Solutions Private Limited